Growth Metrics

Palisade Bio (PALI) Leases (2020 - 2025)

Palisade Bio (PALI) reported Leases of $22000.0 for Q2 2025, down 84.51% year-over-year from $142000.0 in Q2 2024, and down 58.49% on a QoQ basis from $53000.0 in Q1 2025.

Palisade Bio (PALI) has 6 years of Leases data on file, last reported at $22000.0 in Q2 2025.

  • Quarterly Leases fell 84.51% year-over-year to $22000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $22000.0 (down 84.51% YoY) and the FY2024 annual result came in at $84000.0, down 57.58% from the prior year.
  • Leases slipped to $22000.0 in Q2 2025 per PALI's latest filing, from $53000.0 in the prior quarter.
  • Across five years, Leases topped out at $363000.0 in Q2 2022 and bottomed at $22000.0 in Q2 2025.
  • The 5-year median for Leases is $170000.0 (2024), against an average of $178764.7.
  • The widest annual swing landed in 2023, when Leases surged 329.69%; it then plunged 84.51% in 2025.
  • Tracing PALI's Leases over 5 years: stood at $109000.0 in 2021, then jumped by 175.23% to $300000.0 in 2022, then plunged by 34.0% to $198000.0 in 2023, then slumped by 57.58% to $84000.0 in 2024, then slumped by 73.81% to $22000.0 in 2025.
  • Per Business Quant, the three latest PALI Leases figures stand at $22000.0 (Q2 2025), $53000.0 (Q1 2025), and $84000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 61,822.50
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 189.30 Mn
10 Palisade Bio 439.25 Mn 309.68 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 22,000.00
Mar 31, 2025 53,000.00
Dec 31, 2024 84,000.00
Sep 30, 2024 113,000.00
Jun 30, 2024 142,000.00
Mar 31, 2024 170,000.00
Dec 31, 2023 198,000.00
Sep 30, 2023 224,000.00
Jun 30, 2023 250,000.00
Mar 31, 2023 275,000.00
Dec 31, 2022 300,000.00
Sep 30, 2022 324,000.00
Jun 30, 2022 363,000.00
Mar 31, 2022 64,000.00
Dec 31, 2021 109,000.00
Sep 30, 2021 153,000.00
Jun 30, 2021 195,000.00
Dec 31, 2020 275,000.00